| Compound:
~ Export ~
|
Records:708
| Gene |
Compound |
Gen_sig |
Exp_pattern |
| GUSBP11 |
S-(dimethylarsino)-3-mercapto-1,2-propyl dibenzoate |
0.008 |
Down |
| GUSBP11 |
NSC 724771 |
0.021 |
Down |
| GUSBP11 |
(1S,4R,5R,12R,13S)-9-[(2-{[(1S,4R,5R,8R,12R,13S)-1,5-dimethy l)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadec -9-en-9-yl]methoxy}ethoxy)methyl]-1,5-dimethyl-10-(trifluoro methyl)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]he xadec-9-ene |
0.017 |
Down |
| GUSBP11 |
(1S,4R,5R,8R,12R,13S)-1,5-dimethyl-9-methylene-11,14,15,16-t etraoxatetracyclo[10.3.1.04,13.08,13]hexadec-10-yl]oxy}-3-he xenyl)oxy]-1,5,-dimethyl-9-methylene-11,14,15,16-tetraoxatet racyclo[10.3.1.04,13.08,13]hexadecane |
0.034 |
Down |
| GUSBP11 |
2-[(Dimethylamino)-1-ethyl]-5,6-dihydro-2,3-dimethoxy-8,9-me thylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Formic Acid |
0.022 |
Down |
| GUSBP11 |
NSC 725127 |
0.042 |
Down |
| GUSBP11 |
6-[3-(Bis-hydroxyethylamino)-1-propyl]-5,6-dihydro-2,3-~ dimethoxy-8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline hydrochloride |
0.035 |
Down |
| GUSBP11 |
6-[(3-Thiazolylamino)-1-propyl]-5,6-dihydro-2,3-dimethoxy-~ 8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline hydrochloride |
0.016 |
Down |
| GUSBP11 |
Waol A FD-211 |
0.011 |
Down |
| GUSBP11 |
2,2'-(1,4-phenylene)bis(1,3-dimethylimidazolidine) |
0.003 |
Down |
| GUSBP11 |
NSC 726373 |
0.016 |
Up |
| GUSBP11 |
1-(3-diethylarsino-3-thio-2-methyl-1-oxopropyl)-L-proline |
0.001 |
Down |
| GUSBP11 |
1, 1'[Pentane-1,5-diyl)dioxy]bis(11as)-2-fluoro-7-methoxy-1,2,3 ,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one |
0.039 |
Down |
| GUSBP11 |
2-carboxy-(2'-furyl)-7-chloro-3-trifluoromethylquinoxaline 1,4-dioxide |
0.047 |
Down |
| GUSBP11 |
6-(3-Aminopropyl)-5,6-dihydro-8,9-methylenedioxy-5,11-dioxo- 3-nitro-11H-indeno[1,2-c]isoquinoline Hydrochloride Salt |
0.016 |
Down |
Expression pattern: Sensitivity / Resistance
Total:48 Current:43
First Prev Next Last 
|